Antti Sakari Rannikko (A Rannikko, Antti S Rannikko, Antti Rannikko)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Venues

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

BJU international

medRxiv : the preprint server for health sciences

International journal of cancer

Helsingin Yliopisto Laaketieteellinen tiedekunta

Turun Yliopisto (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Helsingin Yliopisto Laaketieteellinen tiedekunta

Finland

Senior consultant :: Urology

Education History

Turun Yliopisto

Finland

PHD :: Physiology

Publications

Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Aksnessæther, Maiju Pesonen, Kristian Thon, Torgrim Tandstad, Teemu Murtola, Mads Hvid Poulsen, Tobias Nordström, Maria Nyre Vigmostad, Fredrik Ottosson, Karin Holmsten, Ola Christiansen, Marit Slaaen, Erik Skaaheim Haug, Anne Holck Storås, Lars Asphaug, Antti Sakari Rannikko, Klaus Brasso, null null
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P). BJU international 133 (6) (2024)
Juho Pylväläinen, Jaakko Hoffström, Anu Kenttämies, Anssi Auvinen, Tuomas K Mirtti, Antti Sakari Rannikko
Risk of Clinically Significant Prostate Cancer after a Nonsuspicious Prostate MRI-A Comparison with the General Population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (5) (2024)
Abderrahim Oussama Batouche, Eugen Czeizler, Timo-Pekka K Lehto, Andrew M Erickson, Tolou Shadbahr, Teemu Daniel Laajala, Joona Pohjonen, Andrew Julian Vickers, Tuomas K Mirtti, Antti Sakari Rannikko
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment. medRxiv : the preprint server for health sciences (2024)
Juho Pylväläinen, Jaakko Hoffström, Anu Kenttämies, Anssi Auvinen, Tuomas K Mirtti, Antti Sakari Rannikko
Risk of Clinically Significant Prostate Cancer after a Nonsuspicious Prostate MRI-A Comparison with the General Population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (5) (2024)
Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Aksnessaether, Maiju Pesonen, Kristian Thon, Torgrim Tandstad, Teemu Murtola, Mads Hvid Poulsen, Tobias Nordström, Maria Nyre Vigmostad, Fredrik Ottosson, Karin Holmsten, Ola Christiansen, Marit Slaaen, Erik Skaaheim Haug, Anne Holck Storås, Lars Asphaug, Antti Sakari Rannikko, Klaus Brasso, null null
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P). BJU international (2024)
Abderrahim Oussama Batouche, Eugen Czeizler, Timo-Pekka K Lehto, Andrew M Erickson, Tolou Shadbahr, Teemu Daniel Laajala, Joona Pohjonen, Andrew Julian Vickers, Tuomas K Mirtti, Antti Sakari Rannikko
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment. medRxiv : the preprint server for health sciences (2024)
Juho Pylväläinen, Jaakko Hoffström, Anu Kenttämies, Anssi Auvinen, Tuomas K Mirtti, Antti Sakari Rannikko
Risk of clinically significant prostate cancer after a non-suspicious prostate MRI - a comparison with the general population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Abderrahim Oussama Batouche, Eugen Czeizler, Timo-Pekka K Lehto, Andrew M Erickson, Tolou Shadbahr, Teemu Daniel Laajala, Joona Pohjonen, Andrew Julian Vickers, Tuomas K Mirtti, Antti Sakari Rannikko
MRI-Targeted Prostate Biopsy Introduces Grade Inflation and Overtreatment. medRxiv : the preprint server for health sciences (2024)
Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Aksnessæther, Maiju Pesonen, Kristian Thon, Torgrim Tandstad, Teemu Murtola, Mads Hvid Poulsen, Tobias Nordström, Maria Nyre Vigmostad, Fredrik Ottosson, Karin Holmsten, Ola Christiansen, Marit Slaaen, Erik Skaaheim Haug, Anne Holck Storås, Lars Asphaug, Antti Sakari Rannikko, Klaus Brasso, null null
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P). BJU international 133 (6) (2024)
Juho Pylväläinen, Jaakko Hoffström, Anu Kenttämies, Anssi Auvinen, Tuomas K Mirtti, Antti Sakari Rannikko
Risk of Clinically Significant Prostate Cancer after a Nonsuspicious Prostate MRI-A Comparison with the General Population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (5) (2024)
Hannu Koistinen, Ruusu-Maaria Kovanen, Morley D Hollenberg, Antoine Dufour, Evette S Radisky, Ulf-Håkan Stenman, Jyotsna Batra, Judith A Clements, John D Hooper, Eleftherios P Diamandis, Oliver Schilling, Antti Sakari Rannikko, Tuomas K Mirtti
The roles of proteases in prostate cancer. IUBMB life (2023)
Hannu Koistinen, Ruusu-Maaria Kovanen, Morley D Hollenberg, Antoine Dufour, Evette S Radisky, Ulf-Håkan Stenman, Jyotsna Batra, Judith A Clements, John D Hooper, Eleftherios P Diamandis, Oliver Schilling, Antti Sakari Rannikko, Tuomas K Mirtti
The roles of proteases in prostate cancer. IUBMB life (2023)
Timo-Pekka K Lehto, Juho Pylväläinen, Kevin Sandeman, Anu Kenttämies, Stig Nordling, Ian G Mills, Jing Tang, Tuomas K Mirtti, Antti Sakari Rannikko
Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis. International journal of cancer (2023)
Timo-Pekka K Lehto, Ruusu-Maaria Kovanen, Susanna Lintula, Adrian Malén, Carolin Stürenberg, Andrew M Erickson, Olli-Pekka Pulkka, Ulf-Håkan Stenman, Eleftherios P Diamandis, Antti Sakari Rannikko, Tuomas K Mirtti, Hannu Koistinen
Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer. International journal of cancer (2023)
Timo-Pekka K Lehto, Ruusu-Maaria Kovanen, Susanna Lintula, Adrian Malén, Carolin Stürenberg, Andrew M Erickson, Olli-Pekka Pulkka, Ulf-Håkan Stenman, Eleftherios P Diamandis, Antti Sakari Rannikko, Tuomas K Mirtti, Hannu Koistinen
Prognostic impact of kallikrein-related peptidase transcript levels in prostate cancer. International journal of cancer (2023)
Antti Sakari Rannikko, Mare Leht, Tuomas K Mirtti, Anu Kenttämies, Teemu Tolonen, Irina Rinta-Kiikka, Tuomas P Kilpeläinen, Kari Natunen, Hans G Lilja, Terho Lehtimäki, Jani Raitanen, Paula Kujala, Johanna Ronkainen, Mika Matikainen, Anssi Petas, Kimmo Taari, Teuvo L J Tammela, Anssi Auvinen
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study. BJU international 130 (2) (2022)
Teijo Pellinen, Kevin Sandeman, Sami Blom, Riku Turkki, Annabrita Hemmes, Katja Välimäki, Juho Eineluoto, Anu Kenttämies, Stig Nordling, Olli Kallioniemi, Antti Sakari Rannikko, Tuomas K Mirtti
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer. Cancer research communications 2 (3) (2022)
Teijo Pellinen, Kevin Sandeman, Sami Blom, Riku Turkki, Annabrita Hemmes, Katja Välimäki, Juho Eineluoto, Anu Kenttämies, Stig Nordling, Olli Kallioniemi, Antti Sakari Rannikko, Tuomas K Mirtti
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer. Cancer research communications 2 (3) (2022)
Timo-Pekka K Lehto, Carolin Stürenberg, Adrian Malén, Andrew M Erickson, Hannu Koistinen, Ian Geoffrey Mills, Antti Sakari Rannikko, Tuomas K Mirtti
Transcript analysis of commercial prostate cancer risk stratification panels in hard-to-predict grade group 2-4 prostate cancers. The Prostate 81 (7) (2021)
Andrew M Erickson, Utku Lokman, Kanerva Lahdensuo, Sara Tornberg, Harri Visapaa, Robin Bergroth, Henrikki Santti, Anssi Petas, Antti Sakari Rannikko, Tuomas K Mirtti
PTEN and ERG expression in MRI-ultrasound guided fusion biopsy correlated with radical prostatectomy findings in men with prostate cancer. The Prostate 80 (13) (2020)
Victor Cervera-Carrascon, Dafne C A Quixabeira, Joao Manuel Santos, Riikka Havunen, Sadia Zafar, Otto Hemminki, Camilla Heiniö, Eleonora Munaro, Mikko Siurala, Suvi Sorsa, Tuomas K Mirtti, Petrus Järvinen, Markus Mildh, Harry Nisen, Antti Sakari Rannikko, Marjukka Anttila, Anna Kanerva, Akseli Hemminki
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition. Oncoimmunology 9 (1) (2020)
Ivan Jambor, Janne Verho, Otto O Ettala, Juha Knaapila, Pekka Taimen, Kari T Syvänen, Aida Steiner, Esa Kähkönen, Ileana Montoya Perez, Marjo Seppänen, Antti Sakari Rannikko, Outi Oksanen, Jarno Riikonen, Sanna Mari Vimpeli, Tommi Kauko, Harri Merisaari, Markku Kallajoki, Tuomas Mirtti, Tarja Lamminen, Jani Saunavaara, Hannu J Aronen, Peter J Boström
Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial. PLoS medicine 16 (6) (2019)
Susanna Lintula, Tuomas Mirtti, Antti Sakari Rannikko, Anna Bützow, Anna Lempiäinen, Jakob Stenman, Ulf-Håkan Stenman, Kristina Hotakainen
Tumor expression of human chorionic gonadotropin beta mRNA and prognosis of prostate cancer treated by radical prostatectomy. Scandinavian journal of clinical and laboratory investigation 79 (6) (2019)
Bassem R Haddad, Andrew Erickson, Vindhya Udhane, Peter S LaViolette, Janice D Rone, Markku A Kallajoki, William A See, Antti Sakari Rannikko, Tuomas Mirtti, Marja T Nevalainen
Positive STAT5 Protein and Locus Amplification Status Predicts Recurrence after Radical Prostatectomy to Assist Clinical Precision Management of Prostate Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28 (10) (2019)
Johan Stranne, Martin Andreas Røder, B Brennhovd, E Johansson, Fredrik Jäderling, M Kouri, Wolfgang A Lilleby, P Meidahl Petersen, Tuomas K Mirtti, A Pettersson, Antti Sakari Rannikko, Camilla Thellenberg Karlsson, Olof Akre
SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer. Scandinavian journal of urology 52 (5-6) (2018)

Antti Sakari Rannikko.css-eqlu8i{font-size:small;padding-left:4px;} (A Rannikko, Antti S Rannikko, Antti Rannikko)

Publication Activity (10 Years)

Top Topics

Top Venues

Antti Sakari Rannikko (A Rannikko, Antti S Rannikko, Antti Rannikko)